Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332.
Sheri L. Spunt(BVI (United States)), Alberto S. Pappo(St. Jude Children's Research Hospital), William H. Meyer(Lawrence Livermore National Laboratory), Lynn Million(VA Palo Alto Health Care System), Simon C. Kao(University of Iowa), Beth McCarville(St. Jude Children's Research Hospital), James R. Anderson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rose Anne Speights(St. Jude Children's Research Hospital), David M. Parham(Children's Hospital of Los Angeles), R. Lor Randall(University of California Davis Medical Center), Andrea Hayes‐Jordan(The University of Texas MD Anderson Cancer Center), Stephanie A. Terezakis(Johns Hopkins University), Suzanne L. Wolden(Memorial Sloan Kettering Cancer Center), Jennifer O. Black(Children's Hospital Colorado), Ellen Kawashima(Children's Oncology Group), Douglas S. Hawkins(Seattle Children's Hospital), Fran Laurie(University of Massachusetts Chan Medical School), Cheryl M. Coffin(University of Utah), Stephen X. Skapek(Duke University)
Cited by 30
Related Papers
Germline Mutations in Predisposition Genes in Pediatric Cancer
|New England Journal of Medicine|2015|1.4k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636